Piper Sandler Reiterates Overweight on Illumina, Raises Price Target to $225
Illumina, Inc.
Illumina, Inc. ILMN | 0.00 |
Piper Sandler analyst David Westenberg reiterates Illumina (NASDAQ:
ILMN) with a Overweight and raises the price target from $200 to $225.
